VBI Vaccines
VBIV
HK$0.51
Share price
0.00%
Change (1 day)
-92.95%
Change (1 year)
Categories
Revenue for VBI Vaccines (VBIV)
Revenue in 2024 (TTM): HK$73.68 Million
According to VBI Vaccines
's latest financial reports the company's current revenue (TTM 
) is HK$73.16 Million. In 2023 the company made a revenue of HK$67.8 Million an increase over the revenue in the year 2022 that were of HK$8.45 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for VBI Vaccines from 1998 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | HK$73.68 M | 8.66% |
| 2023 | HK$67.8 M | 702.07% |
| 2022 | HK$8.45 M | 71.82% |
| 2021 | HK$4.92 M | -40.18% |
| 2020 | HK$8.22 M | -52.45% |
| 2019 | HK$17.29 M | -34.16% |
| 2018 | HK$26.27 M | 288.75% |
| 2017 | HK$6.75 M | 59.04% |
| 2016 | HK$4.24 M | 483.27% |
| 2015 | HK$0.72 M | |
| 2014 | N/A | |
| 2013 | N/A | |
| 2012 | N/A | |
| 2011 | N/A | |
| 2010 | N/A | |
| 2009 | N/A | |
| 2000 | HK$0.52 M | -67.23% |
| 1999 | HK$1.6 M | 3.86% |
| 1998 | HK$1.54 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | HK$1.75 M | -97.60% | 🇺🇸 USA |
 | HK$6.51 B | 8,800.22% | 🇺🇸 USA |
 | HK$84.8 M | 15.91% | 🇺🇸 USA |